Other Funds

GoalsGetter Nikko AM ARK Disruptive Innovation Fund

About the fund

This fund provides access to a global share portfolio that offers thematic exposure to disruptive innovation across a number of sectors and geographies.

Disruptive innovation is caused by the introduction of new technologically enabled products or services that permanently change an industry or economic sector by providing greater simplicity, accuracy, customisation and accessibility while driving down costs.

Risk Indicator (volatility)

1
2
3
4
5
6
7 Extremely high

Target Asset Allocation

Growth 100.00%

Commentary

As of 30 June 2024

Market Highlights

  • Major stock markets rose in June compared to the previous month, driven by some large-cap stocks, on the back of the view that the inflation rate has resumed its downward trend.
  • By sector, Technology, Communication Services, and Consumer Discretionary sectors outperformed on balance in June, while the Utilities, Materials, and Industrials sectors lagged.



Key contributors for the month include Tesla (TSLA), Palantir (PLTR) and Roblox (RBLX).

Shares of Tesla contributed to performance during the month on the back of several pieces of company-specific news. Some notable events include shareholders re-approving Elon Musk's 2018 pay package during the annual shareholder meeting. Tesla released Full-Self-Driving (FSD) v12.4 to limited customers, removing the steering wheel nag and enabling limited hands-free rides. Additionally, Tesla reportedly began testing FSD in China and announced that two Optimus humanoid robots are now working autonomously in the factory. Palantir contributed positively to the fund this month. At the end of May, it was reported that Palantir won an additional $480M contract with the Department of Defence. It was also announced that Palantir would supply data management solutions for Starlab, a commercial space station. Roblox contributed positively to the fund this month after a sell-off following its first-quarter earnings results. Additionally, management has hinted at experimenting with AI creation tools for developers.

Key detractors for the month include 10X Genomics (TXG), Moderna (MRNA) and Unity Software (U).

10X genomics was a detractor to the fund this month, despite beginning the commercial shipment of its new Xenium Prime 5K Pan-Tissue and Pathways panel, which features new enhancements. Moderna detracted from the fund this month after its RSV vaccine proved about 50% effective after 18 months, trailing rival shots. Moreover, at the ASCO conference, Moderna presented encouraging data showing its mRNA-4157 vaccine in combination with Merk’s KEYTRUDA, reduced the risk of cancer spreading or death in high-risk melanoma patients. Unity was a detractor this month as the stock continued to decline given the recent management turnover. Despite management turnover, Unity remains the premier game engine for developers.

Performance

GoalsGetter KiwiSaver Scheme
Open Close

Performance

at 30 June 2024
One month Three months One year Three years (p.a) Five years (p.a)
Fund performance1 2.45% -10.87% 2.96% -25.35%
Appropriate Market Index (AMI)2 6.96% 5.93% 31.36% 16.36%
  1. Returns are before tax and after the deduction of fees and expenses and including tax credits (if any).
  2. AMI: NASDAQ-100 Notional Net Total Return Index in NZD.

5 year cumulative performance $10,000 invested

Nikko AM KiwiSaver Scheme

Top 10 Holdings

Security Name Percentage
Tesla Motors Inc 9.15%
Coinbase Global Inc 6.56%
Roku Inc 6.25%
Roblox Corp 5.28%
Block Inc 5.19%
Robinhood Markets Inc 5.10%
Palantir Technologies Inc 4.54%
Zoom Video Communications Inc 3.78%
Shopify Inc 3.77%
Meta Platforms Inc 3.53%